The groundbreaking rise of Viagra has long been a benchmark of pharmaceutical success, however its legacy within the broader industry now triggers questions about long-term gains. Alternative versions are undercutting patent protection , leading to worries that betting on companies significantly dependent to Viagra's once-dominant standing could… Read More